Role of IL-10 in the abnormalities of early cell activation events of lymphocytes from patients with systemic lupus erythematosus

Journal of Autoimmunity

Volumn 11, Issue 5, 1998, Pages 395-402

  González Amaro, Roberto ^a,b   Portales Pérez, Diana ^a   Baranda, Lourdes ^a   Abud Mendoza, Carlos ^a   Llorente, Luis ^c   Richaud Patin, Yvonne ^c   Alcocer Varela, Jorge ^c   Alarcón Segovia, Donato ^c  

^a UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^c NONE

Author keywords

CD69; Cellular activation; IL 10; Lymphocytes; Systemic lupus erythematosus

Indexed keywords

CD19 ANTIGEN; CD3 ANTIGEN; CD69 ANTIGEN; INTERLEUKIN 10 ANTIBODY; MONOCLONAL ANTIBODY; PHORBOL 13 ACETATE 12 MYRISTATE; PROTON; RECOMBINANT INTERLEUKIN 10; SODIUM ION; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; CELL DEATH; CELL PH; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FLUORESCENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; LYMPHOCYTE ACTIVATION; MONONUCLEAR CELL; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0032192043     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1998.0228     Document Type: Conference Paper

References (38)

1. 1. Moore K., O'Garra A., de Waal Malefyt R., Vieira P., Mosmann T.R. 1993. Interleukin-10. Annu. Rev. Immunol. 11: 165-183
2. 2. Mehrotra P.T., Donnelly R.P., Wong S., Kanegane H., Geremew A., Mostowski H.S., Foruke K., Siegel J.P., Bloom E.T. 1998. Production of IL-10 by human natural killer cells stimulated with IL-2 and/or IL-12. J. Immunol. 160: 2637-2644
3. 3. Burdin N., Rousset F., Banchereau J. 1997. B-cell-derived IL-10: production and function. Methods 11: 98-111
4. 4. Cohen S.B., Parry S.L., Feldmann M., Foxwell B.M. 1997. Autocrine and paracrine regulation of human IL-10 production. J. Immunol. 158: 5596-5602
5. 5. Taga K., Mostowski H., Tosato G. 1993. Human interleukin-10 can directly inhibit T-cell growth. Blood 81: 2964-2971
6. 6. Itoh K., Hirohata S. 1995. The role of IL-10 in human B cell activation, proliferation and differentiation. J. Immunol. 154: 4341-4350
7. 7. Estaquier J., Marguerite M., Sahuc F., Bessis N., Auriault C., Ameisen J.C. 1997. Interleukin-10-mediated T cell apoptosis during the T helper type cytokine response in murine Schistosoma mansoni parasite infection. Eur. Cytokine Net. 8: 153-160
8. 8. Cohen S.B., Crawley J.B., Kahan M.C., Feldmann M., Foxwell B.M. 1997. Interleukin-10 rescues T cells from apoptotic death: association with an up-regulation of Bcl-2. Immunology 92: 1-5
9. 9. Li L., Krajewski S., Reed J.C., Choi Y.S. 1997. The apoptosis and proliferation of SAC-activated B cells by IL-10 are associated with changes in Bcl-2, Bcl-xL, and Mcl-1 expression. Cell. Immunol. 178: 33-41
10. 10. Georgescu L., Krishna-Vakkalanka R., Elkon K.B., Crow M.K. 1997. Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand. J. Clin. Invest. 100: 2622-2633
11. 11. Llorente L., Richaud-Patin Y., Fior R., Alcocer-Varela J., Wijdenes J., Fourier B.M., Galanaud P., Emilie D. 1994. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arthritis Rheum. 37: 1647-1655
12. 12. Fuss I.J., Strober W., Dale J.K., Fritz S., Pearlstein G.R., Puck J.M., Lenardo M.J., Straus S.E. 1997. Characteristic T helper 2 cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunity. J. Immunol. 158: 1912-1918
13. 13. Mills J.A. 1994. Systemic lupus erythematosus. N. Engl. J. Med. 330: 1871-1879
14. 14. Klinman D.M. 1993. B cell abnormalities characteristic of systemic lupus erythematosus. In Dubois' lupus erythematosus. D.J. Wallace and B.H. Hans, eds. Lea & Febiger, Philadelphia, pp 77-82
15. 15. Horwitz D.A., Stohl W. 1993. Abnormalities in T lymphocytes (in systemic lupus erythematosus). In Dubois' lupus erythematosus. D.J. Wallace and B.H. Hans, eds. Lea & Febiger, Philadelphia, pp 83-96
16. 2+ during activation of lymphocytes from patients with systemic lupus erythematosus. Lupus 6: 48-56
17. + T cells in systemic lupus erythematosus: alterations associated with prednisolone therapy. Scand. J. Immunol. 31: 139-143
18. 18. Wigfall D.R., Sakai R.S., Wallace D.J., Jordan S.C. 1988. Interleukin-2 receptor expression in peripheral blood lymphocytes from systemic lupus erythematosus patients: relationship to clinical activity. Clin. Immunol. Immunopathol. 47: 354-360
19. 19. Llorente L., Richaud-Patin Y., Wijdenes J., Alcocer-Varela J., Maillot M.C., Durand-Gasselin I., Fourrier B.M., Galanaud P., Emilie D. 1993. Spontaneous production of interleukin-1 by B lymphocytes and monocytes in systemic lupus erythematosus. Eur. Cytokine Net. 4: 421-427
20. 20. Houssiau F.A., Lefebvre C., van den Berghe M., Lambert M., Devogelaer J.P., Renauld J.C. 1995. Serum interleukin 10 titres in systemic lupus erythematosus reflect disease activity. Lupus 4: 393-395
21. + T cell-B cell antibody synthesis. J. Clin. Immunol. 16: 198-207
22. 22. Liu T.F., Jones B.M. 1998. Impaired production of IL-12 in systemic lupus erythematosus, I: Excessive production of IL-10 suppresses production of IL-12 by monocytes. Cytokine 10: 140-147
23. 23. Llorente L., Richaud-Patin Y., Couderc J., Alarcón-Segovia D., Ruiz-Soto R., Alcocer-Castillejos N., Alcocer-Varela J., Granados J., Bahena S., Galanaud P., Emilie D. 1997. Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus. Arthritis Rheum. 40: 1429-1435
24. 24. Llorente L., Zou W., Levy Y., Richaud-Patin Y., Wijdenes J., Alcocer-Varela J., Morel-Fourrier B., Brouet J.C., Alarcón-Segovia D., Galanaud P., Emilie D. 1995. Role of interleukin-10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J. Exp. Med. 181: 839-844
25. 25. Tan E.M., Cohen A.S., Fries F., Masi A.T., McShane D.J., Rothfield N.F., Schaller J.G., Talal N., Winchester R.J. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25: 1271-1277
26. + exchange activity in cells from bone marrow transplantation recipients. J. Immunol. 143: 2185-2192
27. 27. Sánchez-Armáss S., Martínez-Zaguilán R., Martínez G.M., Gillies R.J. 1994. Regulation of pH in rat brain synaptosomes, I: Role of sodium, bicarbonate and potassium. J. Neurophysiol. 71: 2236-2247
28. + exchanger in a leukemic T cell line. J. Biol. Chem. 260: 14053-14059
29. 29. Cebrián M., Redondo J.M., López-Rivas A., Rodríguez-Tarduchi G., de Landazuri M.O., Sánchez-Madrid F. 1989. Expression and function of AIM, an activation inducer molecule of human lymphocytes is dependent on the activation of protein kinase C. Eur. J. Immunol. 19: 809-815
30. 30. Hagenbaugh A., Sharma S., Dubinett S.M., Wei S.H.Y., Aranda R., Cheroutre H., Fowell D.J., Binder S., Tsao B., Locksley R.M., Moore K.W., Kronenberg M. 1997. Altered immune responses in interleukin-10 transgenic mice. J. Exp. Med. 185: 2101-2110
31. 31. Mongan A.E., Ramdahin S., Warrington R.J. 1997. Interleukin-10 response abnormalities in systemic lupus erythematosus. Scand. J. Immunol. 46: 406-412
32. 32. Ishida H., Muchamuel T., Sakaguchi S., Andrade S., Menon S., Howard M. 1994. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J. Exp. Med. 179: 305-310
33. 33. Kalechman Y., Gafter U., Da J.P., Albeck M., Alarcón-Segovia D., Sredni B. 1997. Delay in the onset of systemic lupus erythematosus following treatment with the immunomodulator AS101: association with IL-10 inhibition and increase in TNF-α levels. J. Immunol. 159: 2658-2667
34. 34. Finbloom D.S., Winestock K.D. 1995. IL-10 induces the tyrosine phosphorylation of tky2 and jak1 and the differential assembly of STAT1α and STAT3 complexes in human T cells and monocytes. J. Immunol. 155: 1079-1090
35. 35. Geng Y., Gulbins E., Altman A., Lotz M. 1994. Monocyte deactivation by interleukin-10 via inhibition of tyrosine phosphorylation activity and the ras signaling pathway. Proc. Natl. Acad. Sci. USA 91: 8602-8609
36. + T cells. J. Exp. Med. 184: 19-29
37. 37. O'Garra A., Murphy K. 1994. Role of cytokines in determining T lymphocyte function. Curr. Opin. Immunol. 6: 458-464
38. + T cells in systemic lupus erythematosus (SLE) and the relation with activation-induced apoptosis. Clin. Exp. Immunol. 106: 218-229